{
    "success": true,
    "data": {
        "id": 1396473,
        "msgid": "high-quality-price-stability-commitment-to-customers-1447893297",
        "date": "1998-10-15 00:00:00",
        "title": "High quality, price stability commitment to customers",
        "author": null,
        "source": "",
        "tags": null,
        "topic": null,
        "summary": "High quality, price stability commitment to customers PT Meiji Indonesia is a pioneer of quality antibiotic products for both domestic and international markets. This is the unique and clear image of PT Meiji Indonesia, a company highly specialized in pharmaceuticals.",
        "content": "<p>High quality, price stability commitment to customers<\/p>\n<p>PT Meiji Indonesia is a pioneer of quality antibiotic products<br>\nfor both domestic and international markets. This is the unique<br>\nand clear image of PT Meiji Indonesia, a company highly<br>\nspecialized in pharmaceuticals.<\/p>\n<p>For the past 24 years, it has produced over 215 million vials,<br>\n500 million capsules and 500 million tablets, under such medicine<br>\ntrade marks as Troches, Viccillin, Dibekacin, Kanamycin and<br>\nMeixam; all have been used by producers throughout Indonesia, the<br>\nASEAN region and Japan.<\/p>\n<p>All products are guaranteed high quality, with integrated<br>\nsupervision supported by Meiji Seika Kaisha Ltd Japan standards<br>\nand certified by the Indonesian government to local medical<br>\nproduction standards. Products consist of 99 percent prescription<br>\ndrugs and 1 percent over-the-counter medicines for the domestic<br>\nmarket.<\/p>\n<p>The company and its employees share a perception concerning<br>\nthe relationship between production quality and employees<br>\nwelfare: \"Employee enhancement brings company enhancement, and<br>\ncompany enhancement translates into improved employee benefits.\"<br>\nPT Meiji Indonesia has won 16 awards at regional as well as<br>\nnational levels, including one for environmental consciousness<br>\nand a subregional first prize for the implementation of norm K3<br>\nChemical industry sector.<\/p>\n<p>PT Meiji Indonesia's President Director, T. Nakazono, pays<br>\nmajor attention to pricing. He is committed to keeping prices<br>\naffordable for the public despite the fact that real market<br>\nprices have increased from April by 45 percent to 75 percent. It<br>\nis untrue, he said, that because of the economic crisis medicine<br>\nprices have increased 200 percent. If this has happened, he said,<br>\nit is because of a distribution factor or too many speculators.<\/p>\n<p>Nakazono suggested making a pharmaceutical association which<br>\ncould control price stability. And the government should carry<br>\nout tight supervision in order to eliminate speculators and to<br>\nstabilize the distribution process and prices of raw materials.<\/p>",
        "url": "https:\/\/jawawa.id\/newsitem\/high-quality-price-stability-commitment-to-customers-1447893297",
        "image": ""
    },
    "sponsor": "Okusi Associates",
    "sponsor_url": "https:\/\/okusiassociates.com"
}